ID: ALA4216655

Max Phase: Preclinical

Molecular Formula: C29H34N4O4

Molecular Weight: 502.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@@H]1CN(C)[C@H]2Cc3c([nH]c4ccccc34)/C(=N/N=C\c3ccc(O)c(OC)c3)C[C@H]1[C@H]2C(=O)OC

Standard InChI:  InChI=1S/C29H34N4O4/c1-5-18-16-33(2)24-14-21-19-8-6-7-9-22(19)31-28(21)23(13-20(18)27(24)29(35)37-4)32-30-15-17-10-11-25(34)26(12-17)36-3/h6-12,15,18,20,24,27,31,34H,5,13-14,16H2,1-4H3/b30-15-,32-23+/t18-,20-,24+,27-/m1/s1

Standard InChI Key:  SPGGMUWGQXRFQX-YTKCTSSESA-N

Associated Targets(Human)

Multidrug resistance-associated protein 1 2587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

ATP-binding cassette sub-family G member 2 4927 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BHK-21 725 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NIH3T3 5395 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 502.62Molecular Weight (Monoisotopic): 502.2580AlogP: 4.40#Rotatable Bonds: 5
Polar Surface Area: 99.51Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.42CX Basic pKa: 9.55CX LogP: 3.73CX LogD: 2.86
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.31Np Likeness Score: 0.68

References

1. Paterna A, Khonkarn R, Mulhovo S, Moreno A, Madeira Girio P, Baubichon-Cortay H, Falson P, Ferreira MU..  (2018)  Monoterpene indole alkaloid azine derivatives as MDR reversal agents.,  26  (2): [PMID:29233614] [10.1016/j.bmc.2017.11.052]

Source